GILD- May  15 Calls bought

    Posted by ssaffer on 6th of Mar 2020 at 01:16 pm

    GILD- May  15 Calls bought this am  $90@3.0.  I am reading stories of some US patients that are getting a new drug to help them and seem to be recovering.  I do not have inside information but looking at the map, GILD is the only company that I have read that has an antiviral drug and vaccine that were both in Phase 3 trials.  Most other companies are in Phase 1 and 2, now that doesn't mean that they cannot get fast tracked and start human trials.  I just like GILD and their position of strength right now and the long term chart ( I posted last night of a Monthly cup and handle).  

Newsletter

Subscribe to our email list for regular free market updates
as well as a chance to get coupons!